about
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureMicroevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data.Transferrin C2 and Alzheimer's disease: another piece of the puzzle found?Changes in Host Immune-Endocrine Relationships during Tuberculosis Treatment in Patients with Cured and Failed Treatment Outcomes.Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease.Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting.Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa.Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis diseaseTowards eliminating bias in cluster analysis of TB genotyped dataPotential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic areaEvolution of the IS6110-based restriction fragment length polymorphism pattern during the transmission of Mycobacterium tuberculosis.Stability of variable-number tandem repeats of mycobacterial interspersed repetitive units from 12 loci in serial isolates of Mycobacterium tuberculosis.Spoligotype signatures in the Mycobacterium tuberculosis complex.The Risk of Tuberculosis Reinfection Soon after Cure of a First Disease Episode Is Extremely High in a Hyperendemic Community.Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response.Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa.Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex.Stability of polymorphic GC-rich repeat sequence-containing regions of Mycobacterium tuberculosisRise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa.Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis.Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease.Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers.Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistanceTransmission of tuberculosis in a high incidence urban community in South Africa.Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics.Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?Mapping of IS6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticity.IS6110 insertions in Mycobacterium tuberculosis: predominantly into coding regions.Mycobacterial interspersed repetitive-unit-variable-number tandem-repeat analysis and Beijing/W family of Mycobacterium tuberculosis.Discordance between mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing and IS6110 restriction fragment length polymorphism genotyping for analysis of Mycobacterium tuberculosis Beijing strains in a setting of high incideDrug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain.Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area.Ethambutol resistance testing by mutation detection.Strain families of Mycobacterium tuberculosis.
P50
Q28391110-FD3E5ED4-3C6B-4941-A9EB-AD82AF40A35FQ30749810-C0B28B30-42EB-47A1-BF27-77E6D49F3F05Q33366903-4595C34B-E160-478E-BD39-05F22601591CQ33811132-E9409753-7B77-4FAA-8B31-40C3F83B2B37Q33905078-BF236F11-DCC1-421C-A9CA-A18D420CAC4FQ33964588-2383D370-E139-4F3D-B478-6785F1546799Q34101580-5ECA7016-12C5-494C-9CBD-F5242C0338A9Q34203486-D2EDC74B-A3E2-4BAF-8EBE-3254B70DFDB5Q34222109-1F4D2281-7911-452A-A851-FF0C6F263EF7Q34302593-9452338B-F6F5-4C0A-890F-112EC4A893B1Q34455867-570C9E72-5A8D-4231-ACD5-4A13DECC88D2Q34989729-C04E91F3-6CF9-4A25-AE9F-68C87ADED3A9Q35690253-FD5D816A-4C71-459F-9234-F7DE97FF2ABFQ35864014-5FBF1E2C-1630-47DA-B76E-657A9F061CAFQ36093905-C48DABCC-A43D-4F06-9B77-C19B569E044EQ36240511-C696BD9D-A671-44C7-AA08-0AA7FDF55521Q36240885-9C4C84B9-F79E-4725-89D6-B6F4DEEE43BDQ36539796-0E179A53-F4E1-4ACF-8EAB-572567E29E37Q36597754-00B06A5B-A11E-4515-AA3A-7D2F3E0FD2A0Q37015588-8F8DD1D4-C49E-4F23-B67C-76224E5474EFQ37282989-AEA8D055-06B2-4E8F-9372-47A44DC871A2Q37353352-38BD8E89-CCC2-4A0C-9DD2-4CE1F6C20833Q37416253-A5D4FE36-6EE7-46FD-B8A8-E5760070913FQ37628903-C094C26E-9BC3-4CFA-8019-C0B93054FAF9Q37633072-1AA86B92-14A7-43E8-8EDA-EB12409DEA1BQ37702404-5D42FBF0-9D73-4B24-ABB2-E25C426C054AQ38854712-04204B1A-F8D8-4847-B058-359CDA119C46Q39467097-EFCB3D5C-1B2D-49F7-AE49-2C92BBBBD40BQ39681775-E632DB8F-FC30-408C-AC4F-C637A100E718Q39713565-EA65880C-5B2D-4014-A528-12C1D5CF3F84Q40021876-18528A06-FE2C-4AC3-BDB1-774A7355A3BDQ42479301-B7F03B12-E9A9-4FBD-98AC-9EB20681315DQ42634281-377248D7-0FDE-4959-9353-BE806B8981C6Q42727778-C542ED6F-40AE-413B-81DE-74E785726F24Q42850326-DF23F9DC-E15B-41C5-AFFB-DFAB346D4D05Q42917391-EB8E6CBB-8AC7-4E9C-B307-70A56ACE2718Q43748661-37F3E30A-6481-471C-B432-35B25CDBA877Q46791842-EBF23468-263B-47D0-8D47-CB31E0CFA338Q46861131-220CD97F-BA2C-4C67-9017-B0D9C9A3FB61Q46884418-739BD49B-A4CB-4745-B2BA-3D04EB1E0970
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gian D Van Der Spuy
@ast
Gian D Van Der Spuy
@en
Gian D Van Der Spuy
@es
Gian D Van Der Spuy
@nl
type
label
Gian D Van Der Spuy
@ast
Gian D Van Der Spuy
@en
Gian D Van Der Spuy
@es
Gian D Van Der Spuy
@nl
prefLabel
Gian D Van Der Spuy
@ast
Gian D Van Der Spuy
@en
Gian D Van Der Spuy
@es
Gian D Van Der Spuy
@nl
P106
P31
P496
0000-0002-9067-5903